Kexing Biopharm Co., Ltd. (SHA:688136)
China · Delayed Price · Currency is CNY 18.43
+0.62 (3.48%)
Aug 4, 2026, 3:00 PM CST
Kexing Biopharm Market Cap
Kexing Biopharm has a market cap or net worth of 3.52 billion as of August 4, 2026. Its market cap has decreased by -67.90% in one year.
Market Cap
3.52B
Enterprise Value
4.31B
Revenue
1.46B
Ranking
n/a
PE Ratio
31.40
Stock Price
18.43
ChartMarket Cap Chart
Since December 14, 2020, Kexing Biopharm's market cap has decreased from 8.15B to 3.52B, a decrease of -56.75%. That is a compound annual growth rate of -13.82%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 3, 2026 | 3.52B | -43.83% |
| Dec 31, 2025 | 6.27B | 45.13% |
| Dec 31, 2024 | 4.32B | 7.17% |
| Dec 29, 2023 | 4.03B | -5.31% |
| Dec 30, 2022 | 4.26B | -24.16% |
| Dec 31, 2021 | 5.62B | -30.78% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 14, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Hefei Lifeon Pharmaceutical | 3.85B |
| Jiangsu Sihuan Bioengineering | 3.72B |
| Beijing Scitop Bio-tech | 3.67B |
| Pulike Biological Engineering | 3.55B |
| Assure Tech (Hangzhou) | 3.55B |
| Boji Medical Technology | 3.51B |
| Shanghai Obio Technology (Group) Corp. | 3.48B |
| Shanghai Shen Lian Biomedical | 3.42B |